Viol Co Ltd
KOSDAQ:335890
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
6 770
11 730
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Viol Co Ltd
Cash Equivalents
Viol Co Ltd
Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
V
|
Viol Co Ltd
KOSDAQ:335890
|
Cash Equivalents
₩23.5B
|
CAGR 3-Years
148%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dentium Co Ltd
KRX:145720
|
Cash Equivalents
₩99.6B
|
CAGR 3-Years
17%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
|
B
|
Biodyne Co Ltd
KOSDAQ:314930
|
Cash Equivalents
₩9.7B
|
CAGR 3-Years
48%
|
CAGR 5-Years
47%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jeisys Medical Inc
KOSDAQ:287410
|
Cash Equivalents
₩52.9B
|
CAGR 3-Years
32%
|
CAGR 5-Years
115%
|
CAGR 10-Years
N/A
|
|
|
C
|
Classys Inc
KOSDAQ:214150
|
Cash Equivalents
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
L
|
Lutronic Corp
KOSDAQ:085370
|
Cash Equivalents
₩50B
|
CAGR 3-Years
67%
|
CAGR 5-Years
70%
|
CAGR 10-Years
33%
|
|
Viol Co Ltd
Glance View
VIOL Co., Ltd. is engaged in the provision of financial support services. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2019-12-03. The firm's main product is Scarlet, an equipment for elasticity and lifting. In addition, the Company develops and produces medical devices for anti-aging skin care. The firm sells its products in domestic and overseas markets such as China and the United States.
See Also
What is Viol Co Ltd's Cash Equivalents?
Cash Equivalents
23.5B
KRW
Based on the financial report for Dec 31, 2023, Viol Co Ltd's Cash Equivalents amounts to 23.5B KRW.
What is Viol Co Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 3Y
148%
Over the last year, the Cash Equivalents growth was 129%. The average annual Cash Equivalents growth rates for Viol Co Ltd have been 148% over the past three years .
You don't have any saved screeners yet